Close Menu

Guardant Health

Of the 28 companies in the index, 18 firms saw their stock prices increase, while 10 firms' share prices decreased. 

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

News items for the in vitro diagnostics industry for the week of June 8, 2020.

The company, along with Softbank Investment Advisers, is offering a total of 11.5 million shares of its common stock at $84 per share.

Several groups are developing diagnostic viral genome sequencing assays and panels, which promise high sensitivity and additional information on viral origin and spread.

The company is creating a high-throughput NGS test for healthcare workers and the underserved, and to support viral surveillance programs for large employers.

The firm's precision oncology testing revenue more than doubled to $60.2 million, while its development services revenues contracted 7 percent.

A study of both tissue and blood samples from patients in a small trial found that liquid biopsy may detect putative resistance mutations missed in tissue.

Of the 28 companies in the index, nine companies' share prices increased while the share values of 19 declined month over month.  

Pages